At Binghamton University, researchers were among the first to find ways to help patients with Duchenne muscular dystrophy ...

SAT-3247 has now received FDA Fast Track, Orphan Drug and Rare Pediatric Disease designations for Duchenne muscular dystrophy (“Duchenne” or “DMD”) Fast Track is designed to expedite the ...

Jamesy Raffone of Manalapan is defying the experts, learning to drive despite Duchenne muscular dystrophy. The man least shocked is his father.

Burn Boot Camp totals $3.8 million in donations to MDA’s mission since 2016. Burn Boot Camp and Muscular Dystrophy ...

Dyne pursues rare disease breakthroughs while Vertex leverages blockbuster profits for pipeline expansion, how do their risk ...

Dyne is advancing therapies for rare muscle diseases while Viking targets the booming weight-loss market. See how their ...

GeneTAC® small molecule designed to selectively reduce transcription of the mutant DMPK allele and address the underlying cause of DM1CARLSBAD, ...

Parent Project Muscular Dystrophy (PPMD), the leading U.S. non-profit driving Duchenne and Becker muscular dystrophy care, research, and advocacy efforts, will host its 2026 Annual Conference in ...

Epicrispr's epigenetic editor EPI-321 lead to an average increase in lean muscle of about 0.8 pounds six months after treatment. (iStock / Getty Images Plus) Epicrispr Biotechnologies has used its ...

Duchenne Muscular Dystrophy (DMD) is a severe, X-linked genetic disorder characterized by progressive muscle degeneration affecting the skeletal, respiratory, and cardiac muscles.

As of Tuesday, June 30, Design Therapeutics, Inc.’s DSGN share price has surged by 5.06%, which has investors questioning if ...

SAT-3247 has now received FDA Fast Track, Orphan Drug and Rare Pediatric Disease designations for Duchenne muscular dystrophy ("Duchenne" or "DMD")Fast Track is designed to expedite the development/re ...